Raziel Therapeutics is a pharmaceutical company developing a proprietary drug for the treatment of local fat reduction.The Jerusalem-based company is developing an injectable drug to correct the imbalance caused by consuming more calories than the body normally can burn. The drug generates heat from the fatty acids produced by fat cells, melting away those cells and postponing the proliferation of new fat cells.

TPCera develops a new type of immunomodulatory compound that shifts the immune system from an inflammatory state into an anti-inflammatory one.